Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer
Felicia Zhang Perkins, Xiuli Zhang, Yik Y. L. Yu, Yilin Yang et autres
0 citationsScience Advances
Elizabeth M. Jaffee
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
1468Publications signalées
58173Citations signalées
7Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchImmunotherapy and Immune ResponsesCAR-T cell therapy researchCancer Genomics and Diagnostics
Publications récentes
Supplemental Figure 9 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Table 6 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 13 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Table 2 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 4 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 15 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 7 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 3 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Data from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Figure 10 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
Supplemental Table 1 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors
Howard L. Li, Soren Charmsaz, Chester Kao, Carlotta Pazzi et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.